ARDELYX INC. - COMMON
5.3500
26-十一月-24 15:45:00
15 分钟延时
股票
+0.1000
+1.90%
今日范围
5.1600 - 5.3700
ISIN
N/A
来源
NASDAQ
-
Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
20 11月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ardelyx Responds to District Court Decision Granting Motion to Dismiss
08 11月 2024 11:31:21 条件 Nasdaq GlobeNewswire
-
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference
05 11月 2024 07:00:32 条件 Nasdaq GlobeNewswire
-
Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update
31 10月 2024 15:02:40 条件 Nasdaq GlobeNewswire
-
28 10月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
24 10月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
22 10月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
21 10月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024
17 10月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
09 10月 2024 07:05:00 条件 Nasdaq GlobeNewswire
-
Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference
05 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
08 8月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update
01 8月 2024 15:01:02 条件 Nasdaq GlobeNewswire
-
31 7月 2024 07:02:00 条件 Nasdaq GlobeNewswire
-
Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024
18 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
17 7月 2024 16:10:43 条件 Nasdaq GlobeNewswire
-
To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA
02 7月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
28 6月 2024 07:17:59 条件 Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
30 5月 2024 15:02:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >